|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.060 USD | -4.50% |
|
-4.50% | -54.51% |
| 10-26 | Spero Therapeutics, Inc. Announces Executive Changes | CI |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 64.64M | - | - | - | - | - |
| 64.38B | |||||
| 56.16B | |||||
| 54.16B | |||||
| 45.33B | |||||
| 42.25B |
Select your edition
All financial news and data tailored to specific country editions
